Intuitive Surgical (NASDAQ:ISRG) Trading 1.3% Higher – Should You Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG) shares rose 1.3% during trading on Thursday . The company traded as high as $584.08 and last traded at $580.02. Approximately 400,239 shares traded hands during trading, a decline of 79% from the average daily volume of 1,931,788 shares. The stock had previously closed at $572.71.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ISRG. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Down 1.4 %

The stock has a market cap of $203.69 billion, a P/E ratio of 89.22, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39. The firm has a 50 day simple moving average of $550.40 and a 200-day simple moving average of $508.94.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,843 shares of company stock worth $15,357,560. Company insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Mirador Capital Partners LP increased its position in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the period. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.